Steve Damment
Founder at Aluztura Bio Ltd.
Steve Damment active positions
Companies | Position | Start | End |
---|---|---|---|
Aluztura Bio Ltd. | Founder | 01/01/2014 | - |
Corporate Officer/Principal | 01/01/2014 | - |
Career history of Steve Damment
Former positions of Steve Damment
Companies | Position | Start | End |
---|---|---|---|
BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 01/06/2018 | 30/09/2021 |
Corporate Officer/Principal | 01/05/2015 | 01/06/2018 | |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01/01/2000 | 01/12/2013 |
GSK PLC | Corporate Officer/Principal | 01/07/1982 | 01/12/1999 |
Training of Steve Damment
The University of Liverpool | Undergraduate Degree |
Statistics
International
United Kingdom | 6 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
GSK PLC | Health Technology |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Private companies | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Aluztura Bio Ltd. |
- Stock Market
- Insiders
- Steve Damment
- Experience